Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study

BACKGROUND: Some current evidence is pointing towards an association between COVID-19 and worsening of multiple sclerosis (MS), stressing the importance of preventing COVID-19 among people with MS (pwMS). However, population-based evidence regarding the long-term post-COVID-19 course of relapsing-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Etemadifar, Masoud, Abhari, Amir Parsa, Nouri, Hosein, Salari, Mehri, Maleki, Shiva, Amin, Alireza, Sedaghat, Nahad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861623/
https://www.ncbi.nlm.nih.gov/pubmed/35193507
http://dx.doi.org/10.1186/s12883-022-02590-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861623/
https://www.ncbi.nlm.nih.gov/pubmed/35193507
http://dx.doi.org/10.1186/s12883-022-02590-9

Ejemplares similares